{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:48:14Z","timestamp":1790344094094,"version":"4.1.0"},"reference-count":30,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Introduction: Despite the advancements in diagnostic methods and antibiotic treatment, empyema is a critical respiratory infection, showing a high mortality rate of 10\u201325%. Patients and Methods: To evaluate the bacterial etiology and prognostic factors of acute empyema, we conducted this long-term retrospective cohort study at our institute between 2008 and 2022. Results: A total of 80 patients were enrolled in this cohort. The median age was 72 years (range 19 to 93 years), and 61 (76%) were male. The most common underlying disease was malignancy, seen in 28 (35%). The mean Charlson comorbidity index (CCI) was 2.7 (\u00b12.4). The 30-day and in-hospital mortality were 9 (11%) and 15 (19%), respectively. Univariate analysis revealed that healthcare-associated infection, inappropriate treatment, high CCI score, performance status (PS) of 2\u20134, and isolation of potentially drug-resistant (PDR) pathogens were poor prognostic factors. Finally, multivariate analysis showed that high CCI score (p = 0.009) and isolation of PDR pathogens (p = 0.011) were independent poor prognostic factors for in-hospital death in acute empyema. Conclusions: We found that higher CCI scores and isolation of PDR pathogens were independent poor prognostic factors for in-hospital mortality among empyema patients.<\/jats:p>","DOI":"10.3390\/antibiotics13121205","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T06:44:05Z","timestamp":1733899445000},"page":"1205","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A 15-Year Observational Cohort of Acute Empyema at a Single-Center in Japan"],"prefix":"10.3390","volume":"13","author":[{"given":"Nobuhiro","family":"Asai","sequence":"first","affiliation":[{"name":"Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"},{"name":"Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"},{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Clinical Research Center, Aichi Medical University, Nagakute 480-1195, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"},{"name":"Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sakanashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"},{"name":"Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-9560","authenticated-orcid":false,"given":"Hideo","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"},{"name":"Department of Pharmacy, Mie University Hospital, Tsu 514-0001, Mie, Japan"},{"name":"Department of Clinical Pharmaceutics, Division of Clinical Medical Science, Mie University Graduate School of Medicine, Tsu 514-0001, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"},{"name":"Department of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Nagakute 480-1195, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suematsu","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"},{"name":"Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[{"name":"Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"},{"name":"Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1378\/chest.104.5.1486","article-title":"The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia","volume":"104","author":"Marel","year":"1993","journal-title":"Chest"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zettinig, D., D\u2019Antonoli, T.A., Wilder-Smith, A., Bremerich, J., Roth, J.A., and Sexauer, R. (2021). Diagnostic Accuracy of Imaging Findings in Pleural Empyema: Systematic Review and Meta-Analysis. J. Imaging, 8.","DOI":"10.3390\/jimaging8010003"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jiac.2017.04.011","article-title":"The etiology and bacteriology of healthcare-associated empyema are quite different from those of community-acquired empyema","volume":"23","author":"Asai","year":"2017","journal-title":"J. Infect. Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa042473","article-title":"UK Controlled trial of intrapleural streptokinase for pleural infection","volume":"352","author":"Maskell","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jtcvs.2006.09.038","article-title":"Management of pleural space infections: A population-based analysis","volume":"133","author":"Farjah","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/qjmed\/89.4.285","article-title":"The clinical course and management of thoracic empyema","volume":"89","author":"Ferguson","year":"1996","journal-title":"QJM"},{"key":"ref_7","first-page":"1427","article-title":"Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: Outcome of 234 patients","volume":"127","author":"Luh","year":"2005","journal-title":"Chest"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jiac.2022.08.001","article-title":"Could quick SOFA and SOFA score be a predictive tool for 30-day and in-hospital mortality in acute empyema?","volume":"28","author":"Asai","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Cheng, Y.F., Chen, C.M., Chen, Y.L., Cheng, C.Y., Huang, C.L., Hung, W.H., and Wang, B.Y. (2023). The outcomes of thoracoscopic decortication between fungal empyema and bacterial empyema. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-022-07978-z"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010-2017: A nationwide surveillance study","volume":"25","author":"Liese","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/INF.0000000000003353","article-title":"Pediatric Parapneumonic Effusion\/Pleural Empyema in Japan: A Nationwide Survey","volume":"41","author":"Hoshino","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","article-title":"Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study","volume":"163","author":"Nagata","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.aambs.2016.08.002","article-title":"The Oral Microbiome in Health and Its Implication in Oral and Systemic Diseases","volume":"97","author":"Caldas","year":"2016","journal-title":"Adv. Appl. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jiac.2021.06.011","article-title":"Ceftriaxone versus tazobactam\/piperacillin and carbapenems in the treatment of aspiration pneumonia: A propensity score matching analysis","volume":"27","author":"Asai","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.resinv.2022.03.002","article-title":"The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy","volume":"60","author":"Asai","year":"2022","journal-title":"Respir. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yagi, K., Huffnagle, G.B., Lukacs, N.W., and Asai, N. (2021). The Lung Microbiome during Health and Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910872"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"L646","DOI":"10.1152\/ajplung.00040.2024","article-title":"Microbiome modifications by steroids during viral exacerbation of asthma and in healthy mice","volume":"327","author":"Yagi","year":"2024","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00432-024-05728-z","article-title":"Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: Analysis of Health Insurance Review and Assessment data","volume":"150","author":"Hong","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101961","DOI":"10.1016\/j.jormas.2024.101961","article-title":"What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?","volume":"125","author":"Kikuta","year":"2024","journal-title":"J. Stomatol. Oral. Maxillofac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2020.03.012","article-title":"Microbiota-immune interactions in asthma pathogenesis and phenotype","volume":"66","author":"Lukacs","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1164\/rccm.201611-2262OC","article-title":"New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study","volume":"196","author":"Ranzani","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF00263530","article-title":"Predicting outcome among intensive care unit patients using computerised trend analysis of daily Apache II scores corrected for organ system failure","volume":"14","author":"Chang","year":"1988","journal-title":"Intensive Care Med."},{"key":"ref_26","unstructured":"Wayne, P. (2011). Performance Standards for Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijid.2019.04.020","article-title":"Efficacy and accuracy of qSOFA and SOFA scores as prognostic tools for community-acquired and healthcare-associated pneumonia","volume":"84","author":"Asai","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"American Thoracic Society, and Infectious Diseases Society of America (2005). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med., 171, 388\u2013416.","DOI":"10.1164\/rccm.200405-644ST"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2169\/internalmedicine.45.1691","article-title":"The JRS guidelines for the management of community-acquired pneumonia in adults: An update and new recommendations","volume":"45","author":"Miyashita","year":"2006","journal-title":"Intern. Med."},{"key":"ref_30","unstructured":"The Ministry of Health, Labour and Welfare (2019, April 15). Alchoholic. Available online: https:\/\/www.mhlw.go.jp\/www1\/topics\/kenko21_11\/b5.html."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/12\/1205\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:52:16Z","timestamp":1760115136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/12\/1205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["antibiotics13121205"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics13121205","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]}}}